A public health expert breaks down the details of the CDC delaying reporting of COVID-19 vaccine benefits, including study ...
That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...
MRNA COVID-19 vaccination and cancer risk are examined in a case report and review that explores a reported temporal ...
The acting CDC director cited concerns with the methodology, but the design has long been used to test vaccine effectiveness.
CDC delays a report showing updated COVID vaccines cut ER visits and hospitalizations by ~50% in healthy adults. Read more ...
CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...
It seems that every time we start to relax, a new Covid-19 variant surfaces. Covid-19 fatigue is real, and many people just aren’t paying attention ...
A growing body of research across multiple countries now points to the same conclusion: COVID-19 vaccines do not raise the ...
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...
Neal Browning pushed this story back into view with a short social media post. Newsweek said he marked the 6-year anniversary ...
The Johns Hopkins Bloomberg School of Public Health hosted a media briefing on March 26, 2026, to discuss mRNA vaccines: how they work, their effectiveness and safety, and their role in responding to ...